6fusion Revenue and Competitors

Location

N/A

Total Funding

Analytics

Industry

Estimated Revenue & Valuation

  • 6fusion's estimated annual revenue is currently $630k per year.(i)
  • 6fusion's estimated revenue per employee is $70,000

Employee Data

  • 6fusion has 9 Employees.(i)
  • 6fusion grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$66.5M3805%N/AN/A
#2
$0.6M90%N/AN/A
#3
$5.3M50-6%$7.7MN/A
#4
$2M290%$7.5MN/A
#5
$2.7M28-10%N/AN/A
#6
$4.1M3922%$3.8MN/A
#7
$1M129%N/AN/A
#8
$2.5M2613%N/AN/A
#9
$6.8M5633%$51.3MN/A
#10
$0.9M110%N/AN/A
Add Company

What Is 6fusion?

6fusion is standardizing the economic measurement of IT infrastructure, bringing together a global marketplace for buyers and sellers of IT infrastructure. 6fusion enables organizations to normalize IT infrastructure usage data to get a clear view of utilization rates, consumption patterns, and cost efficiencies. The Workload Allocation Cube (WAC) creates a standardized unit of measurement that turns IT infrastructure into a utility greatly simplifying consumption allocation reporting and chargeback while also creating an apples to apples comparison allowing users to make effective cloud allocation and infrastructure investment decisions.

keywords:N/A

N/A

Total Funding

9

Number of Employees

$630k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

6fusion News

2022-04-17 - Fusion Biopsy System Market 2022 | Covid19 Impact Analysis ...

Chapter 6: Fusion Biopsy System Production, Consumption, Export, and Import by Regions. Chapter 7: Fusion Biopsy System Market Status and...

2022-03-30 - Therapeutic antibodies against filoviruses including Ebola and Marburg

... 6: fusion loop, 7: Heptad repeat 1 (HR1), 8 and 9: Heptad repeat 2 (HR2); 9: stalk; and 10: and membrane-proximal external region (MPER)...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M9N/AN/A
#2
$3.5M9-18%N/A
#3
$1.4M929%N/A
#4
$0.7M9-10%N/A
#5
$0.7M90%N/A